このエピソードについて
Part 1 has landed!
Join in on their conversation on the Cell and Gene Therapy industry.
Some topics that Darwin and Rajiv discuss in this episode are:
- The current status of cell and gene therapy approvals,
- CMC challenges
- AAV-based gene therapy
Stay tuned to part 2 of their conversation. Remember to subscribe to the podcast to get the latest releases
Rajiv Gangurde LinkedIn profile: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
First episode of 2025 proves to be a great one with Zack Lyon. Listen in.
Part 3 is Here! Join Darwin and Aaron Snyder, VP of Quality at Allotex, as they wrap up with a powerful discussion on career growth, the critical role of career ladders, and how they drive higher retention, stability, and reduced risk in organizations.
Aaron Snyder LinkedIn: https://www.linkedin.…
Just released, Part 2 of Darwin and Rajiv's discussion on Cell and Gene Therapy.
Some topics they discuss are:
- Clinical holds
- Gene Therapy developers and outsourcing
- Evolving regulatory guidance for C>.
Rajiv Gangurde LinkedIn: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
#bi…
Our next guest on the SSI Executive Conversation Podcast is Jennifer Fried, CEO and Co-founder of Flow Medical, a surgical software platform for treating pulmonary embolisms.
Some topics that Darwin and Jennifer discuss are:
- How Flow Medical started
- Why the technology is so significant
- Challe…
免責: このページに埋め込まれているポッドキャストとアートワークは Darwin Shurig からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
